v1
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Identifier:nobleid.org/w1/20260515/6BFDF1F6
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/6BFDF1F6)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims